Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening

Jiajun Qian, Shan Peng, Jie Gao, Yao Fu, Haifeng Huang, Cheng Wu, Weidong Gan, Xuefeng Qiu, Hongqian Guo · 2025

Read Patient-derived organoids based on targeted biopsy of primary prostate cancer: development, identification, and drug screening by Jiajun Qian, Shan Peng, Jie Gao, Yao Fu, Haifeng Huang, Cheng Wu, Weidong Gan, Xuefeng Qiu, Hongqian Guo (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12713212.txt.

Description

Jiajun Qian and co-authors describe a 2025 lab method for growing small tumor copies from prostate cancer. Fresh tumor tissue came from men who had a targeted biopsy at their center. The team grew the tissue as tiny balls of cells, called organoids, and then checked how well the copies matched the real tumors.

Stains and gene tests showed the copies kept the same look and the same gene changes as the source tumors. Drug tests then showed that copies from different men reacted in different ways to three drugs. The authors say such copies could help predict which drug may work for a given man.

Catalog record

CREATORJiajun Qian, Shan Peng, Jie Gao, Yao Fu, Haifeng Huang, Cheng Wu, Weidong Gan, Xuefeng Qiu, Hongqian Guo
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE20 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12713212

Browse the full library · About the Tower of Babel